Inhibition of HIV-1 infection by zinc group metal compounds

Antiviral Research

Volumn 43, Issue 2, 1999, Pages 123-133

  Haraguchi, Yuji ^a   Sakurai, Hiromu ^b   Hussain, Saver ^c   Anner, Beatrice M ^c   Hoshino, Hiroo ^a  

^a GUNMA UNIVERSITY   (Japan)

^b KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^c UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Cadmium; Inhibition of HIV 1 production; Mercury; Zinc

Indexed keywords

CADMIUM ACETATE; CADMIUM DERIVATIVE; GAG PROTEIN; MERCURY DERIVATIVE; NUCLEOCAPSID PROTEIN; ORGANOMETALLIC COMPOUND; VIRUS PROTEIN; ZINC ACETATE; ZINC CHLORIDE; ZINC DERIVATIVE;

ANTIVIRAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DNA SYNTHESIS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS TRANSCRIPTION;

ANTIVIRAL AGENTS; CADMIUM COMPOUNDS; CELL DIVISION; CELL LINE; DNA, VIRAL; GIANT CELLS; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; MERCURY COMPOUNDS; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; TRANSCRIPTION, GENETIC; VIRUS REPLICATION; ZINC COMPOUNDS;

EID: 0032871976     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(99)00040-6     Document Type: Article

References (18)

1. Adler A.D., Longo F.R., Kampa F., Kim J. J. Inorg. Nucl. Chem. 32:1970;2443.
2. Dimitrov D.S., Broder C.C., Berger E.A., Blumenthal R. Calcium ions are required for cell fusion mediated by the CD4-human immunodeficiency virus type 1 envelope glycoprotein interaction. J. Virol. 67:1993;1647-1652.
3. Fitzgerald D.W., Coleman J.E. Physicochemical properties of cloned nucleocapsid protein from HIV. Interactions with metal ions. Biochemistry. 30:1991;5195-5201.
4. Frankel A.D., Bredt D.S., Pabo C.O. Tat protein from human immunodeficiency virus forms a metal-linked dimer. Science. 240:1988;70-73.
5. Haraguchi Y., Takeuchi Y., Hoshino H. Inhibition of plating of human T cell leukemia virus type I and syncytium-inducing types of human immunodeficiency virus type 1 by polycations. AIDS Res. Human Retrovir. 13:1997;1517-1523.
6. Ikeda R., Haraguchi Y., Ikeda Y., Kondo S., Takeuchi T., Hoshino H. Inhibition of human immunodeficiency virus type 1 infectivity by a new amine bellenamine. Antiviral Res. 29:1996;163-173.
7. Karlistrom A.R., Levine R.L. Copper inhibits the protease from human immunodeficiency virus 1 by cysteine-dependent and cysteine-independent mechanisms. Proc. Natl. Acad. Sci. USA. 88:1991;5552-5556.
8. Kikukawa R., Koyanagi Y., Harada S., Kobayashi N., Hatanaka M., Yamamoto N. Differential susceptibility to the acquired immunodeficiency syndrome retrovirus in cloned cells of human leukemic T-cell line Molt-4. J. Virol. 57:1986;1159-1162.
9. Koken S.E.C., Greijer A.E., Verhoef K., van Wamel J., Bukrinskaya A.G., Berkhout B. Intracellular analysis of in vitro modified HIV Tat protein. J. Biol. Chem. 18:1994;8366-8375.
10. Miyoshi I., Kubonishi I., Yoshimoto S., Akagi T., Ohtuki Y., Shiraishi Y., Nagata K., Hinuma Y. Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukemic T cells. Nature. 294:1981;770-771.
11. 2+-dependent 3′-processing activity of human immunodeficiency virus type 1 integrase in vitro. Biochemistry. 35:1996;3837-3844.
12. Nakashima H., Tanabe A., Tochikura T.S., Yamamoto N. Rapid screening method with a cell multisizer for inhibitors of human immunodeficiency virus-induced cell fusion in vitro. J. Clin. Microbiol. 26:1988;1229-1232.
13. Osborn L., Kunkel S., Nabel G.J. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc. Natl. Acad. Sci. USA. 86:1989;2336-2340.
14. Popovic M., Sarngadharan M.G., Read E., Gallo R.C. Detection, isolation and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science. 224:1984;497-500.
15. Salahuddin S.Z., Markam P.D., Wong-Staal F., Franchini G., Kalyanaraman V.S., Gallo R.C. Restricted expression of human T-cell leukemia-lymphoma virus (HTLV) in transformed human umbilical cord blood lymphocytes. Virology. 129:1983;51-64.
16. Sommerfelt M.A., Weiss R.A. Receptor interference groups of 20 retroviruses plating on human cells. Virology. 176:1990;58-69.
17. Takeuchi Y., Inagaki M., Kobayashi N., Hoshino H. Isolation of human immunodeficiency virus from a Japanese hemophilia B patients with AIDS. Jpn. J. Cancer Res. 78:1987;11-15.
18. Zang Z.Y., Reardon I.M., Hui J.O., O'Connell K.L., Poorman R.A., Tomasselli A.G., Heinrikson R.L. Zinc inhibition of renin and the protease from human immunodeficiency virus type 1. Biochemistry. 30:1991;8717-8721.